Transfusionsmedizinische Versorgung von Patienten nach allogener Blutstammzelltransplantation
K Hölig, A Rosner - TumorDiagnostik & Therapie, 2019 - thieme-connect.com
Im Rahmen einer allogenen Blutstammzelltransplantation kommt es häufig zu
immunhämatologischen Phänomenen, die im Rahmen der Diagnostik und der supportiven …
immunhämatologischen Phänomenen, die im Rahmen der Diagnostik und der supportiven …
Transfusionsmedizinische Versorgung von Patienten nach allogener Blutstammzelltransplantation
K Hölig, A Rosner - Transfusionsmedizin, 2018 - thieme-connect.com
Im Rahmen einer allogenen Blutstammzelltransplantation kommt es häufig zu
immunhämatologischen Phänomenen, die im Rahmen der Diagnostik und der supportiven …
immunhämatologischen Phänomenen, die im Rahmen der Diagnostik und der supportiven …
Management and cause analysis of platelet transfusion refractoriness
X Huang - Blood&Genomics, 2018 - blood-genomics.com
Platelet transfusion refractoriness (PTR) can be defined as the less increment of platelet
count than expected after platelets transfusion, which is a challenging and expensive …
count than expected after platelets transfusion, which is a challenging and expensive …
[PDF][PDF] Relieving Dyrk1a repression of MKL1 confers an adult-like phenotype to human
KE Elagib, A Brock, C Clementelli… - Biol Blood Marrow …, 2011 - researchgate.net
Infantile (fetal and neonatal) megakaryocytes have a distinct phenotype consisting of
hyperproliferation, limited morphogenesis, and low platelet production capacity. These …
hyperproliferation, limited morphogenesis, and low platelet production capacity. These …
[引用][C] Extended platelet transfusion in bleeding patients with platelet transfusion refractoriness
T Fernández-Barge, JJ Domínguez-García… - … and Apheresis Science, 2023 - trasci.com
PTR results from immune (anti-HLA or anti-HPA antibodies) or, more commonly, non-
immune mechanisms (bleeding, sepsis, fever, or splenomegaly). Bleeding in these patients …
immune mechanisms (bleeding, sepsis, fever, or splenomegaly). Bleeding in these patients …
[引用][C] Finding platelets: Don't let the perfect be the enemy of the good
PAR Brunker, V Pattanayak, GK Mahowald - Transfusion, 2021 - Wiley Online Library
See article on page 2307–2316, in this issue
[引用][C] Sospecha y manejo de la refractariedad plaquetaria
O Rabinovich - Revista Hematología, 2019 - dialnet.unirioja.es
[引用][C] Potential use of IgG endopeptidase in the management of platelet refractoriness due to HLA alloimmunization
JD Burner, D Goldfinger - Transfusion and Apheresis Science, 2018 - trasci.com
HLA antibodies are the most common cause of immune refractoriness in thrombocytopenic
patients requiring repeated platelet transfusions. Management of HLA platelet refractoriness …
patients requiring repeated platelet transfusions. Management of HLA platelet refractoriness …